[Hong Kong, January 22, 2021]Recently, the Great Bay Bio Family celebrated the past year’s achievement in a special way.

The theme of the annual gathering was "Breaking the waves and sailing away from the sea". Through the video, we reviewed the development history of Great Bay Bio in theextraordinary year of 2020, focusing on epidemic prevention with one hand and resumption of work with the other.

The chairman delivered a speech online inHong Kong, affirming the perseverance and dedication of all staff, andadvocating that colleagues of Great Bay Bio should be vigilant in times ofpeace, stay alert, focus on building a benign business closed loop, break the waves and sail straight to the sea in the complex and changing environment, and create further successes!

CEO Dr. Michael Chen delivered a speechwith the theme of "Yesterday, Today, Tomorrow", summarizing the pastdevelopment, present situation and future outlook of Great Bay Bio, emphasizing that our staff should put the market and products in the first place, becustomer-oriented and improve service quality.

In the extraordinary year of 2020, the family members of Great Bay Bio have been in the same boat and overcome the difficulties together. The President's Innovative Newcomer Award, Blue Whale Award, and Great Bay Ten-Year Loyalty and Dedication Award were presented atthe annual meeting to commend the dedicated people who are willing to devote themselves to their work.

The show of this online gathering was recorded in a simple way but we certainly were having such a great time. The company has set up six major prizes, and added extra BOSS and CEO awards, the redenvelopes in the company Wechat group also kept popping up till midnight!

The big wave is coming, and the newchallenge arises in 2021. At this moment, all the colleagues of Great Bay Bio should stay alert, break the waves, sail straight to the sea and create another success!

About GBB

Headquartered in Hong Kong, Great Bay Bio (GBB) is a high-tech enterprisededicated to applying artificial intelligence and other cutting-edgetechnologies to biopharmaceutical development and other blue ocean bio-products,ultimately solving numerous pain points of biopharmaceutical industry,including high failure rates, long development timeline and high costs. Sincethe company’s establishment, it has obtained massive data from conventionalbiologics development in its 3100 m2 CMC facilities which bolster advanceequipment from world-renowned manufacturers. GBB has also successfully broughta number of biologic products to NDA stage, some of which are classified asnational class I innovative drugs. Currently, the company has created theintelligent centralized database, where deep learning is being performed tocreate next generation of AI-enabled bioprocessing ecosystem. To learn more,please visit http://www.greatbay-bio.com.